Skip to main content
TipRanks
Go Ultimate75% OFF

Pharmadrug (PHRX) Stock Statistics & Valuation Metrics

34 Followers

Total Valuation

Pharmadrug has a market cap or net worth of CAD 671.07K. The enterprise value is CAD 2.44M.

Market Cap
CAD 671.07K
Enterprise Value
CAD 2.44M

Share Statistics

Pharmadrug has 134,214,390 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
134,214,390
Owned by Insiders
1.03%
Owned by Institutions
―

Financial Efficiency

Pharmadrug’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is -144.27%.

Return on Equity (ROE)
0.22
Return on Assets (ROA)
-0.69
Return on Invested Capital (ROIC)
-144.27%
Return on Capital Employed (ROCE)
0.17
Revenue Per Employee
0
Profits Per Employee
-42.60K
Employee Count
9
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Pharmadrug is -0.93. Pharmadrug’s PEG ratio is 0.01.

PE Ratio
-0.93
PS Ratio
0.00
PB Ratio
-0.37
Price to FCF
-7.49
Price to Operating Cash Flow
-7.49
PEG Ratio
0.01

Income Statement

In the last 12 months, Pharmadrug had revenue of 0 and earned -383.38K in profits. Earnings per share was -0.00.

Revenue
0
Gross Profit
-50.24K
Operating Income
-225.93K
Pretax Income
-432.50K
Net Income
-383.38K
EBITDA
-71.98K
Earnings Per Share (EPS)
-0.00

Cash Flow

In the last 12 months, operating cash flow was -89.56K and capital expenditures 0, giving a free cash flow of -89.56K billion.

Operating Cash Flow
-89.56K
Free Cash Flow
-89.56K
Free Cash Flow per Share
-0.00

Dividends & Yields

Pharmadrug pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-13.35%
Earnings Yield
-95.53%

Stock Price Statistics

Beta
-1.05
52-Week Price Change
0.00%
50-Day Moving Average
0.01
200-Day Moving Average
0.01
Relative Strength Index (RSI)
―
Average Volume (3m)
14.61K

Important Dates

Pharmadrug upcoming earnings date is Nov 30, 2026, TBA (Not Confirmed).

Last Earnings Date
Aug 27, 2026
Next Earnings Date
Nov 30, 2026
Ex-Dividend Date
―

Financial Position

Pharmadrug as a current ratio of 0.02, with Debt / Equity ratio of -86.14%

Current Ratio
0.02
Quick Ratio
0.02
Debt to Market Cap
0.94
Net Debt to EBITDA
-20.78
Interest Coverage Ratio
-0.73

Taxes

In the past 12 months, Pharmadrug has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Pharmadrug EV to EBITDA ratio is -10.21, with an EV/FCF ratio of -26.24.

EV to Sales
0.00
EV to EBITDA
-10.21
EV to Free Cash Flow
-26.24
EV to Operating Cash Flow
-26.24

Balance Sheet

Pharmadrug has CAD 28.36K in cash and marketable securities with CAD 1.71M in debt, giving a net cash position of -CAD 1.68M billion.

Cash & Marketable Securities
CAD 28.36K
Total Debt
CAD 1.71M
Net Cash
-CAD 1.68M
Net Cash Per Share
-CAD 0.01
Tangible Book Value Per Share
-CAD 0.02

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Pharmadrug is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
―
EPS Growth Forecast
-62.50%

Scores

Smart Score
―
AI Score
41